APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pemirolast

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pemirolast Market Analysis and Forecast 2026-2032

31 December 2025196 pages

Choose your research edition.

Industry ResearchPemirolast Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Pemirolast Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pemirolast Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pemirolast Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pemirolast Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Pemirolast market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pemirolast is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pemirolast is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pemirolast is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pemirolast is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pemirolast include SAMYANG CHEMICAL, SanTen, Vegesna Laboratories, Toronto Research Chemicals, LGM Pharma, Jiaxing Epochem Pharmtech, FEIMA YAOYE, Clearsynth and ChemScence, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pemirolast, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pemirolast, also provides the sales of main regions and countries. Of the upcoming market potential for Pemirolast, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pemirolast sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pemirolast market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pemirolast sales, projected growth trends, production technology, application and end-user industry.

Pemirolast Segment by Company

SAMYANG CHEMICAL

SanTen

Vegesna Laboratories

Toronto Research Chemicals

LGM Pharma

Jiaxing Epochem Pharmtech

FEIMA YAOYE

Clearsynth

ChemScence

AESCU PHARMA

Pemirolast Segment by Type

Drop

Tablet

Other

Pemirolast Segment by Application

Eye Disease

Asthma

Other

Pemirolast Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemirolast market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pemirolast and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemirolast.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pemirolast in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pemirolast manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pemirolast sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pemirolast Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Drop Major Manufacturers Table 3. Tablet Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Pemirolast Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Eye Disease Major Manufacturers Table 7. Asthma Major Manufacturers Table 8. Other Major Manufacturers Table 9. Pemirolast Industry Trends Table 10. Pemirolast Industry Drivers Table 11. Pemirolast Industry Opportunities and Challenges Table 12. Pemirolast Industry Restraints Table 13. Global Pemirolast Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Pemirolast Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Pemirolast Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Pemirolast Revenue Market Share by Region (2021-2026) Table 17. Global Pemirolast Revenue Market Share by Region (2027-2032) Table 18. Global Pemirolast Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Pemirolast Sales by Region (2021-2026) & (K Units) Table 20. Global Pemirolast Sales by Region (2027-2032) & (K Units) Table 21. Global Pemirolast Sales Market Share by Region (2021-2026) Table 22. Global Pemirolast Sales Market Share by Region (2027-2032) Table 23. Global Pemirolast Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pemirolast Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Pemirolast Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pemirolast Sales Market Share by Manufacturers (2021-2026) Table 27. Global Pemirolast Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Pemirolast Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Pemirolast Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Pemirolast Manufacturers, Product Type & Application Table 31. Global Pemirolast Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Pemirolast by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Pemirolast Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pemirolast Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Pemirolast Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Pemirolast Revenue Market Share by Type (2021-2026) Table 38. Global Pemirolast Revenue Market Share by Type (2027-2032) Table 39. Global Pemirolast Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Pemirolast Sales by Type (2021-2026) & (K Units) Table 41. Global Pemirolast Sales by Type (2027-2032) & (K Units) Table 42. Global Pemirolast Sales Market Share by Type (2021-2026) Table 43. Global Pemirolast Sales Market Share by Type (2027-2032) Table 44. Global Pemirolast Price by Type (2021-2026) & (US$/Unit) Table 45. Global Pemirolast Price by Type (2027-2032) & (US$/Unit) Table 46. Global Pemirolast Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pemirolast Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Pemirolast Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Pemirolast Revenue Market Share by Application (2021-2026) Table 50. Global Pemirolast Revenue Market Share by Application (2027-2032) Table 51. Global Pemirolast Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Pemirolast Sales by Application (2021-2026) & (K Units) Table 53. Global Pemirolast Sales by Application (2027-2032) & (K Units) Table 54. Global Pemirolast Sales Market Share by Application (2021-2026) Table 55. Global Pemirolast Sales Market Share by Application (2027-2032) Table 56. Global Pemirolast Price by Application (2021-2026) & (US$/Unit) Table 57. Global Pemirolast Price by Application (2027-2032) & (US$/Unit) Table 58. SAMYANG CHEMICAL Company Information Table 59. SAMYANG CHEMICAL Business Overview Table 60. SAMYANG CHEMICAL Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. SAMYANG CHEMICAL Pemirolast Product Portfolio Table 62. SAMYANG CHEMICAL Recent Development Table 63. SanTen Company Information Table 64. SanTen Business Overview Table 65. SanTen Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. SanTen Pemirolast Product Portfolio Table 67. SanTen Recent Development Table 68. Vegesna Laboratories Company Information Table 69. Vegesna Laboratories Business Overview Table 70. Vegesna Laboratories Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Vegesna Laboratories Pemirolast Product Portfolio Table 72. Vegesna Laboratories Recent Development Table 73. Toronto Research Chemicals Company Information Table 74. Toronto Research Chemicals Business Overview Table 75. Toronto Research Chemicals Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Toronto Research Chemicals Pemirolast Product Portfolio Table 77. Toronto Research Chemicals Recent Development Table 78. LGM Pharma Company Information Table 79. LGM Pharma Business Overview Table 80. LGM Pharma Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. LGM Pharma Pemirolast Product Portfolio Table 82. LGM Pharma Recent Development Table 83. Jiaxing Epochem Pharmtech Company Information Table 84. Jiaxing Epochem Pharmtech Business Overview Table 85. Jiaxing Epochem Pharmtech Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Jiaxing Epochem Pharmtech Pemirolast Product Portfolio Table 87. Jiaxing Epochem Pharmtech Recent Development Table 88. FEIMA YAOYE Company Information Table 89. FEIMA YAOYE Business Overview Table 90. FEIMA YAOYE Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. FEIMA YAOYE Pemirolast Product Portfolio Table 92. FEIMA YAOYE Recent Development Table 93. Clearsynth Company Information Table 94. Clearsynth Business Overview Table 95. Clearsynth Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Clearsynth Pemirolast Product Portfolio Table 97. Clearsynth Recent Development Table 98. ChemScence Company Information Table 99. ChemScence Business Overview Table 100. ChemScence Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. ChemScence Pemirolast Product Portfolio Table 102. ChemScence Recent Development Table 103. AESCU PHARMA Company Information Table 104. AESCU PHARMA Business Overview Table 105. AESCU PHARMA Pemirolast Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. AESCU PHARMA Pemirolast Product Portfolio Table 107. AESCU PHARMA Recent Development Table 108. North America Pemirolast Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Pemirolast Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Pemirolast Sales by Type (2021-2026) & (K Units) Table 111. North America Pemirolast Sales by Type (2027-2032) & (K Units) Table 112. North America Pemirolast Sales Price by Type (2021-2026) & (US$/Unit) Table 113. North America Pemirolast Sales Price by Type (2027-2032) & (US$/Unit) Table 114. North America Pemirolast Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Pemirolast Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Pemirolast Sales by Application (2021-2026) & (K Units) Table 117. North America Pemirolast Sales by Application (2027-2032) & (K Units) Table 118. North America Pemirolast Sales Price by Application (2021-2026) & (US$/Unit) Table 119. North America Pemirolast Sales Price by Application (2027-2032) & (US$/Unit) Table 120. North America Pemirolast Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Pemirolast Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America Pemirolast Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America Pemirolast Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 124. North America Pemirolast Sales by Country (2021-2026) & (K Units) Table 125. North America Pemirolast Sales by Country (2027-2032) & (K Units) Table 126. North America Pemirolast Sales Price by Country (2021-2026) & (US$/Unit) Table 127. North America Pemirolast Sales Price by Country (2027-2032) & (US$/Unit) Table 128. United States Pemirolast Revenue (2021-2032) & (US$ Million) Table 129. Canada Pemirolast Revenue (2021-2032) & (US$ Million) Table 130. Europe Pemirolast Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Pemirolast Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Pemirolast Sales by Type (2021-2026) & (K Units) Table 133. Europe Pemirolast Sales by Type (2027-2032) & (K Units) Table 134. Europe Pemirolast Sales Price by Type (2021-2026) & (US$/Unit) Table 135. Europe Pemirolast Sales Price by Type (2027-2032) & (US$/Unit) Table 136. Europe Pemirolast Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Pemirolast Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Pemirolast Sales by Application (2021-2026) & (K Units) Table 139. Europe Pemirolast Sales by Application (2027-2032) & (K Units) Table 140. Europe Pemirolast Sales Price by Application (2021-2026) & (US$/Unit) Table 141. Europe Pemirolast Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Europe Pemirolast Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Pemirolast Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe Pemirolast Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe Pemirolast Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 146. Europe Pemirolast Sales by Country (2021-2026) & (K Units) Table 147. Europe Pemirolast Sales by Country (2027-2032) & (K Units) Table 148. Europe Pemirolast Sales Price by Country (2021-2026) & (US$/Unit) Table 149. Europe Pemirolast Sales Price by Country (2027-2032) & (US$/Unit) Table 150. Germany Pemirolast Revenue (2021-2032) & (US$ Million) Table 151. France Pemirolast Revenue (2021-2032) & (US$ Million) Table 152. U.K. Pemirolast Revenue (2021-2032) & (US$ Million) Table 153. Italy Pemirolast Revenue (2021-2032) & (US$ Million) Table 154. Netherlands Pemirolast Revenue (2021-2032) & (US$ Million) Table 155. Nordic Countries Pemirolast Revenue (2021-2032) & (US$ Million) Table 156. China Pemirolast Revenue by Type (2021-2026) & (US$ Million) Table 157. China Pemirolast Revenue by Type (2027-2032) & (US$ Million) Table 158. China Pemirolast Sales by Type (2021-2026) & (K Units) Table 159. China Pemirolast Sales by Type (2027-2032) & (K Units) Table 160. China Pemirolast Sales Price by Type (2021-2026) & (US$/Unit) Table 161. China Pemirolast Sales Price by Type (2027-2032) & (US$/Unit) Table 162. China Pemirolast Revenue by Application (2021-2026) & (US$ Million) Table 163. China Pemirolast Revenue by Application (2027-2032) & (US$ Million) Table 164. China Pemirolast Sales by Application (2021-2026) & (K Units) Table 165. China Pemirolast Sales by Application (2027-2032) & (K Units) Table 166. China Pemirolast Sales Price by Application (2021-2026) & (US$/Unit) Table 167. China Pemirolast Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia Pemirolast Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Pemirolast Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Pemirolast Sales by Type (2021-2026) & (K Units) Table 171. Asia Pemirolast Sales by Type (2027-2032) & (K Units) Table 172. Asia Pemirolast Sales Price by Type (2021-2026) & (US$/Unit) Table 173. Asia Pemirolast Sales Price by Type (2027-2032) & (US$/Unit) Table 174. Asia Pemirolast Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Pemirolast Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Pemirolast Sales by Application (2021-2026) & (K Units) Table 177. Asia Pemirolast Sales by Application (2027-2032) & (K Units) Table 178. Asia Pemirolast Sales Price by Application (2021-2026) & (US$/Unit) Table 179. Asia Pemirolast Sales Price by Application (2027-2032) & (US$/Unit) Table 180. Asia Pemirolast Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Pemirolast Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Pemirolast Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Pemirolast Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 184. Asia Pemirolast Sales by Country (2021-2026) & (K Units) Table 185. Asia Pemirolast Sales by Country (2027-2032) & (K Units) Table 186. Asia Pemirolast Sales Price by Country (2021-2026) & (US$/Unit) Table 187. Asia Pemirolast Sales Price by Country (2027-2032) & (US$/Unit) Table 188. Japan Pemirolast Revenue (2021-2032) & (US$ Million) Table 189. South Korea Pemirolast Revenue (2021-2032) & (US$ Million) Table 190. India Pemirolast Revenue (2021-2032) & (US$ Million) Table 191. Australia Pemirolast Revenue (2021-2032) & (US$ Million) Table 192. China Taiwan Pemirolast Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Pemirolast Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Pemirolast Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Pemirolast Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Pemirolast Sales by Type (2021-2026) & (K Units) Table 197. SAMEA Pemirolast Sales by Type (2027-2032) & (K Units) Table 198. SAMEA Pemirolast Sales Price by Type (2021-2026) & (US$/Unit) Table 199. SAMEA Pemirolast Sales Price by Type (2027-2032) & (US$/Unit) Table 200. SAMEA Pemirolast Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Pemirolast Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Pemirolast Sales by Application (2021-2026) & (K Units) Table 203. SAMEA Pemirolast Sales by Application (2027-2032) & (K Units) Table 204. SAMEA Pemirolast Sales Price by Application (2021-2026) & (US$/Unit) Table 205. SAMEA Pemirolast Sales Price by Application (2027-2032) & (US$/Unit) Table 206. SAMEA Pemirolast Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Pemirolast Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Pemirolast Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Pemirolast Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 210. SAMEA Pemirolast Sales by Country (2021-2026) & (K Units) Table 211. SAMEA Pemirolast Sales by Country (2027-2032) & (K Units) Table 212. SAMEA Pemirolast Sales Price by Country (2021-2026) & (US$/Unit) Table 213. SAMEA Pemirolast Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Brazil Pemirolast Revenue (2021-2032) & (US$ Million) Table 215. Argentina Pemirolast Revenue (2021-2032) & (US$ Million) Table 216. Chile Pemirolast Revenue (2021-2032) & (US$ Million) Table 217. Colombia Pemirolast Revenue (2021-2032) & (US$ Million) Table 218. Peru Pemirolast Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Pemirolast Revenue (2021-2032) & (US$ Million) Table 220. Israel Pemirolast Revenue (2021-2032) & (US$ Million) Table 221. UAE Pemirolast Revenue (2021-2032) & (US$ Million) Table 222. Turkey Pemirolast Revenue (2021-2032) & (US$ Million) Table 223. Iran Pemirolast Revenue (2021-2032) & (US$ Million) Table 224. Egypt Pemirolast Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Pemirolast Distributors List Table 228. Pemirolast Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Pemirolast Image Figure 2. Global Pemirolast Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pemirolast Market Size Share 2021 VS 2025 VS 2032 Figure 4. Drop Image Figure 5. Tablet Image Figure 6. Other Image Figure 7. Global Pemirolast Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pemirolast Market Size Share 2021 VS 2025 VS 2032 Figure 9. Eye Disease Image Figure 10. Asthma Image Figure 11. Other Image Figure 12. Global Pemirolast Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pemirolast Revenue (2021-2032) & (US$ Million) Figure 14. Global Pemirolast Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Pemirolast Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Pemirolast Revenue Market Share by Region (2021-2032) Figure 17. Global Pemirolast Sales (2021-2032) & (K Units) Figure 18. Global Pemirolast Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Pemirolast Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Pemirolast Sales YoY (2021-2032) & (K Units) Figure 21. Europe Pemirolast Sales YoY (2021-2032) & (K Units) Figure 22. China Pemirolast Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Pemirolast Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Pemirolast Sales YoY (2021-2032) & (K Units) Figure 25. Global Pemirolast Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Pemirolast Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Pemirolast Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pemirolast Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Pemirolast Revenue Market Share by Type (2021-2032) Figure 31. Global Pemirolast Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Pemirolast Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pemirolast Sales Market Share by Type (2021-2032) Figure 34. Global Pemirolast Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Pemirolast Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Pemirolast Revenue Market Share by Application (2021-2032) Figure 37. Global Pemirolast Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Pemirolast Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pemirolast Sales Market Share by Application (2021-2032) Figure 40. North America Pemirolast Revenue Share by Type (2021-2032) Figure 41. North America Pemirolast Sales Share by Type (2021-2032) Figure 42. North America Pemirolast Revenue Share by Application (2021-2032) Figure 43. North America Pemirolast Sales Share by Application (2021-2032) Figure 44. North America Pemirolast Revenue Share by Country (2021-2032) Figure 45. North America Pemirolast Sales Share by Country (2021-2032) Figure 46. Europe Pemirolast Revenue Share by Type (2021-2032) Figure 47. Europe Pemirolast Sales Share by Type (2021-2032) Figure 48. Europe Pemirolast Revenue Share by Application (2021-2032) Figure 49. Europe Pemirolast Sales Share by Application (2021-2032) Figure 50. Europe Pemirolast Revenue Share by Country (2021-2032) Figure 51. Europe Pemirolast Sales Share by Country (2021-2032) Figure 52. China Pemirolast Revenue Share by Type (2021-2032) Figure 53. China Pemirolast Sales Share by Type (2021-2032) Figure 54. China Pemirolast Revenue Share by Application (2021-2032) Figure 55. China Pemirolast Sales Share by Application (2021-2032) Figure 56. Asia Pemirolast Revenue Share by Type (2021-2032) Figure 57. Asia Pemirolast Sales Share by Type (2021-2032) Figure 58. Asia Pemirolast Revenue Share by Application (2021-2032) Figure 59. Asia Pemirolast Sales Share by Application (2021-2032) Figure 60. Asia Pemirolast Revenue Share by Country (2021-2032) Figure 61. Asia Pemirolast Sales Share by Country (2021-2032) Figure 62. SAMEA Pemirolast Revenue Share by Type (2021-2032) Figure 63. SAMEA Pemirolast Sales Share by Type (2021-2032) Figure 64. SAMEA Pemirolast Revenue Share by Application (2021-2032) Figure 65. SAMEA Pemirolast Sales Share by Application (2021-2032) Figure 66. SAMEA Pemirolast Revenue Share by Country (2021-2032) Figure 67. SAMEA Pemirolast Sales Share by Country (2021-2032) Figure 68. Pemirolast Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pemirolast Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Drop
  • Tablet
  • Other
Applications
  • Eye Disease
  • Asthma
  • Other
Companies covered
  • SAMYANG CHEMICAL
  • SanTen
  • Vegesna Laboratories
  • Toronto Research Chemicals
  • LGM Pharma
  • Jiaxing Epochem Pharmtech
  • FEIMA YAOYE
  • Clearsynth
  • ChemScence
  • AESCU PHARMA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pemirolast Market by Type
  3. 1.2.1 Global Pemirolast Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Drop
  5. 1.2.3 Tablet
  6. 1.2.4 Other
  7. 1.3 Pemirolast Market by Application
  8. 1.3.1 Global Pemirolast Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Eye Disease
  10. 1.3.3 Asthma
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pemirolast Market Dynamics
  1. 2.1 Pemirolast Industry Trends
  2. 2.2 Pemirolast Industry Drivers
  3. 2.3 Pemirolast Industry Opportunities and Challenges
  4. 2.4 Pemirolast Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pemirolast Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pemirolast Revenue by Region
  3. 3.2.1 Global Pemirolast Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pemirolast Revenue by Region (2021-2026)
  5. 3.2.3 Global Pemirolast Revenue by Region (2027-2032)
  6. 3.2.4 Global Pemirolast Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pemirolast Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pemirolast Sales by Region
  9. 3.4.1 Global Pemirolast Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pemirolast Sales by Region (2021-2026)
  11. 3.4.3 Global Pemirolast Sales by Region (2027-2032)
  12. 3.4.4 Global Pemirolast Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pemirolast Revenue by Manufacturers
  2. 4.1.1 Global Pemirolast Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pemirolast Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pemirolast Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pemirolast Sales by Manufacturers
  6. 4.2.1 Global Pemirolast Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pemirolast Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pemirolast Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pemirolast Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pemirolast Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pemirolast Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pemirolast Manufacturers, Product Type & Application
  13. 4.7 Global Pemirolast Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pemirolast Market CR5 and HHI
  16. 4.8.2 2025 Pemirolast Tier 1, Tier 2, and Tier 3
5 Pemirolast Market by Type
  1. 5.1 Global Pemirolast Revenue by Type
  2. 5.1.1 Global Pemirolast Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pemirolast Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pemirolast Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pemirolast Sales by Type
  6. 5.2.1 Global Pemirolast Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pemirolast Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Pemirolast Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pemirolast Price by Type
6 Pemirolast Market by Application
  1. 6.1 Global Pemirolast Revenue by Application
  2. 6.1.1 Global Pemirolast Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pemirolast Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pemirolast Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pemirolast Sales by Application
  6. 6.2.1 Global Pemirolast Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pemirolast Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Pemirolast Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pemirolast Price by Application
7 Company Profiles
  1. 7.1 SAMYANG CHEMICAL
  2. 7.1.1 SAMYANG CHEMICAL Company Information
  3. 7.1.2 SAMYANG CHEMICAL Business Overview
  4. 7.1.3 SAMYANG CHEMICAL Pemirolast Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 SAMYANG CHEMICAL Pemirolast Product Portfolio
  6. 7.1.5 SAMYANG CHEMICAL Recent Developments
  7. 7.2 SanTen
  8. 7.2.1 SanTen Company Information
  9. 7.2.2 SanTen Business Overview
  10. 7.2.3 SanTen Pemirolast Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 SanTen Pemirolast Product Portfolio
  12. 7.2.5 SanTen Recent Developments
  13. 7.3 Vegesna Laboratories
  14. 7.3.1 Vegesna Laboratories Company Information
  15. 7.3.2 Vegesna Laboratories Business Overview
  16. 7.3.3 Vegesna Laboratories Pemirolast Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Vegesna Laboratories Pemirolast Product Portfolio
  18. 7.3.5 Vegesna Laboratories Recent Developments
  19. 7.4 Toronto Research Chemicals
  20. 7.4.1 Toronto Research Chemicals Company Information
  21. 7.4.2 Toronto Research Chemicals Business Overview
  22. 7.4.3 Toronto Research Chemicals Pemirolast Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Toronto Research Chemicals Pemirolast Product Portfolio
  24. 7.4.5 Toronto Research Chemicals Recent Developments
  25. 7.5 LGM Pharma
  26. 7.5.1 LGM Pharma Company Information
  27. 7.5.2 LGM Pharma Business Overview
  28. 7.5.3 LGM Pharma Pemirolast Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 LGM Pharma Pemirolast Product Portfolio
  30. 7.5.5 LGM Pharma Recent Developments
  31. 7.6 Jiaxing Epochem Pharmtech
  32. 7.6.1 Jiaxing Epochem Pharmtech Company Information
  33. 7.6.2 Jiaxing Epochem Pharmtech Business Overview
  34. 7.6.3 Jiaxing Epochem Pharmtech Pemirolast Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jiaxing Epochem Pharmtech Pemirolast Product Portfolio
  36. 7.6.5 Jiaxing Epochem Pharmtech Recent Developments
  37. 7.7 FEIMA YAOYE
  38. 7.7.1 FEIMA YAOYE Company Information
  39. 7.7.2 FEIMA YAOYE Business Overview
  40. 7.7.3 FEIMA YAOYE Pemirolast Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 FEIMA YAOYE Pemirolast Product Portfolio
  42. 7.7.5 FEIMA YAOYE Recent Developments
  43. 7.8 Clearsynth
  44. 7.8.1 Clearsynth Company Information
  45. 7.8.2 Clearsynth Business Overview
  46. 7.8.3 Clearsynth Pemirolast Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Clearsynth Pemirolast Product Portfolio
  48. 7.8.5 Clearsynth Recent Developments
  49. 7.9 ChemScence
  50. 7.9.1 ChemScence Company Information
  51. 7.9.2 ChemScence Business Overview
  52. 7.9.3 ChemScence Pemirolast Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 ChemScence Pemirolast Product Portfolio
  54. 7.9.5 ChemScence Recent Developments
  55. 7.10 AESCU PHARMA
  56. 7.10.1 AESCU PHARMA Company Information
  57. 7.10.2 AESCU PHARMA Business Overview
  58. 7.10.3 AESCU PHARMA Pemirolast Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 AESCU PHARMA Pemirolast Product Portfolio
  60. 7.10.5 AESCU PHARMA Recent Developments
8 North America
  1. 8.1 North America Pemirolast Market Size by Type
  2. 8.1.1 North America Pemirolast Revenue by Type (2021-2032)
  3. 8.1.2 North America Pemirolast Sales by Type (2021-2032)
  4. 8.1.3 North America Pemirolast Price by Type (2021-2032)
  5. 8.2 North America Pemirolast Market Size by Application
  6. 8.2.1 North America Pemirolast Revenue by Application (2021-2032)
  7. 8.2.2 North America Pemirolast Sales by Application (2021-2032)
  8. 8.2.3 North America Pemirolast Price by Application (2021-2032)
  9. 8.3 North America Pemirolast Market Size by Country
  10. 8.3.1 North America Pemirolast Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pemirolast Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pemirolast Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Pemirolast Market Size by Type
  2. 9.1.1 Europe Pemirolast Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pemirolast Sales by Type (2021-2032)
  4. 9.1.3 Europe Pemirolast Price by Type (2021-2032)
  5. 9.2 Europe Pemirolast Market Size by Application
  6. 9.2.1 Europe Pemirolast Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pemirolast Sales by Application (2021-2032)
  8. 9.2.3 Europe Pemirolast Price by Application (2021-2032)
  9. 9.3 Europe Pemirolast Market Size by Country
  10. 9.3.1 Europe Pemirolast Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pemirolast Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pemirolast Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Pemirolast Market Size by Type
  2. 10.1.1 China Pemirolast Revenue by Type (2021-2032)
  3. 10.1.2 China Pemirolast Sales by Type (2021-2032)
  4. 10.1.3 China Pemirolast Price by Type (2021-2032)
  5. 10.2 China Pemirolast Market Size by Application
  6. 10.2.1 China Pemirolast Revenue by Application (2021-2032)
  7. 10.2.2 China Pemirolast Sales by Application (2021-2032)
  8. 10.2.3 China Pemirolast Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pemirolast Market Size by Type
  2. 11.1.1 Asia Pemirolast Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pemirolast Sales by Type (2021-2032)
  4. 11.1.3 Asia Pemirolast Price by Type (2021-2032)
  5. 11.2 Asia Pemirolast Market Size by Application
  6. 11.2.1 Asia Pemirolast Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pemirolast Sales by Application (2021-2032)
  8. 11.2.3 Asia Pemirolast Price by Application (2021-2032)
  9. 11.3 Asia Pemirolast Market Size by Country
  10. 11.3.1 Asia Pemirolast Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pemirolast Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pemirolast Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pemirolast Market Size by Type
  2. 12.1.1 SAMEA Pemirolast Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pemirolast Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pemirolast Price by Type (2021-2032)
  5. 12.2 SAMEA Pemirolast Market Size by Application
  6. 12.2.1 SAMEA Pemirolast Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pemirolast Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pemirolast Price by Application (2021-2032)
  9. 12.3 SAMEA Pemirolast Market Size by Country
  10. 12.3.1 SAMEA Pemirolast Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pemirolast Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pemirolast Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pemirolast Value Chain Analysis
  2. 13.1.1 Pemirolast Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pemirolast Production Mode & Process
  6. 13.2 Pemirolast Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pemirolast Distributors
  9. 13.2.3 Pemirolast Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst